ARYC is trading for .002/share!!!!! That's 1/5 of a penny per share!! No increase in OS or AS in the past 9 months and there is great news re sales and contracts!! If you have averaged down, bought at these levels, you're position is positive.
Arrayit Corporation 927 Thompson Place Sunnyvale, CA 94085 USA Phone 408-744-1331 FAX 408-744-1711 Email arrayit@arrayit.com Web www.arrayit.com
ARYC is on its way up and if you have been following ARYC on L2, you will see that share prices are moving slowly but steadily upwards over the past few months. It is a real company, real products and earnings of $2.3m last year and over $7 million this year!!Please DD and see that ARYC share price has bottomed and a small investment of $5000 could net a return of $100,000 to $500,000. Don't miss opportunity my friends. Don't get dissuaded by negativity on the board (including one mod!) Do not believe what they have to say. A lot of money can be made by purchasing shares at this level. Please DD and research what's about to happen here.
Market Cap $765,953 Shares Outstanding 696.32 million
ARYC also owns 40 million shares of AVDX. A value of $9 million +
Arrayit Corporation (ARYC) @Arrayit leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life™
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit customers in Toronto Canada use Arrayit microarray technology to publish advance on heart transplantation http:// journals.plos.org/plosone/articl e?id=10.1371/journal.pone.0151224 …
Arrayit enters introductory discussions with top life sciences marketing agency Chempetitive https:// chempetitive.com
Arrayit customers in Tel Aviv Israel use Arrayit microarray technology to publish bioprosthetic heart valve advance http:// onlinelibrary.wiley.com/doi/10.1111/x
Arrayit featured in global market microarray growth study by top analysts Biopharma Research http://www. biopharma-resear
Arrayit reports $18,500 microarray platform sale life sciences leader ChemBio Moscow Russia http://www. chembio.russia ssia
Arrayit reports record blood card sales in Q3-16 on microarray immunoassay research apps http://www.arrayit.com/Produc @arrayit
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.